Potential Application of Temozolomide in Mesenchymal Stem Cell-Based TRAIL Gene Therapy Against Malignant Glioma

Because the tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) selectively kills tumor cells, it is one of the most promising candidates for cancer treatment. TRAIL-secreting human mesenchymal stem cells (MSC-TRAIL) provide targeted and prolonged delivery of TRAIL in glioma therapy. How...

Полное описание

Сохранить в:
Библиографические подробности
Главные авторы: Kim, Seong Muk, Woo, Ji Sun, Jeong, Chang Hyun, Ryu, Chung Heon, Jang, Jae-Deog, Jeun, Sin-Soo
Формат: Artigo
Язык:Inglês
Опубликовано: AlphaMed Press 2014
Предметы:
Tissue-Specific Progenitor and Stem Cells
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC3925057/
https://ncbi.nlm.nih.gov/pubmed/24436439
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5966/sctm.2013-0132
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы